Purchase this article with an account.
M. S. Dhalla, G. K. Shah, K. J. Blinder, E. H. Ryan, Jr., R. A. Mittra, A. Tewari; Combined Intravitreal Bevacizumab and Photodynamic Therapy With Verteporfin for Choroidal Neovascularization in Age Related Macular Degeneration. Invest. Ophthalmol. Vis. Sci. 2007;48(13):3389.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
To report the 12-month results for patients treated with combined photodynamic therapy (PDT) with verteporfin and intravitreal bevacizumab for choroidal neovascularization secondary to age related macular degeneration (AMD).
This is a retrospective review of 24 treatment naïve eyes that received intravitreal bevacizumab and PDT with verteporfin within a 14 day interval.
Main outcome measures will be visual acuity stabilization (defined as no change in visual acuity or a gain in visual acuity) and retreatment rate.
The results of this study will be helpful in defining what future role combination therapy may play in the treatment of neovascular AMD.Data will be available in January 2007.
This PDF is available to Subscribers Only